ACSO Accesso Technology Group

Hardman & Co publication on accesso Technology Group (ACSO): We expect revenue growth to accelerate

Hardman & Co Research
Hardman & Co publication on accesso Technology Group (ACSO): We expect revenue growth to accelerate

18-Feb-2025 / 16:05 GMT/BST
The issuer is solely responsible for the content of this announcement.


Hardman & Co Research on accesso Technology Group (ACSO):

We expect revenue growth to accelerate
 

In this note, we review the prospects for accesso ahead of the final results in April.  The January update was reassuring, with revenue of ca.$152m ahead of our $150m forecast and the ca.15% cash EBITDA margin well ahead of the 13.2% forecast. Conservatively, we maintained our FY25 and FY26 forecast. However, as accesso is a growth technology company with a leading market position, we expect revenues to gradually accelerate from 6% in FY25E into the high single digits, and margins to rise as the group focuses on high-margin transactional revenues. Nevertheless, the shares trade on a modest ca.13x our FY26E earnings.

 

Please click on the link below for the full report:

If you are interested in meeting the company, you can register your interest by clicking on the above link.

To contact us:

Hardman & Co
9 Bonhill Street

London

EC2A 4DJ

Follow us on X  

Contact:

Richard Jeans



 

 



 

Hardman & Co Research can still be accessed for free after MiFID II. Please to read the statement.

About Hardman & Co: Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259. Attention is drawn to the important disclaimers at the end of the report.



Dissemination of a CORPORATE NEWS, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

2088167  18-Feb-2025 

fncls.ssp?fn=show_t_gif&application_id=2088167&application_name=news&site_id=research_pool~~~9efe1c65-8ece-4ff7-9608-f21c8e0a38a3
EN
18/02/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Accesso Technology Group

Richard Jeans
  • Richard Jeans

accesso Technology Group (ACSO): We expect revenue growth to accelerat...

In this note, we review the prospects for accesso ahead of the final results in April. The January update was reassuring, with revenue of ca.$152m ahead of our $150m forecast and the ca.15% cash EBITDA margin well ahead of the 13.2% forecast. Conservatively, we maintained our FY25 and FY26 forecast. However, as accesso is a growth technology company with a leading market position, we expect revenues to gradually accelerate from 6% in FY25E into the high single digits, and margins to rise as the...

 PRESS RELEASE

Hardman & Co publication on accesso Technology Group (ACSO): We expect...

Hardman & Co Research Hardman & Co publication on accesso Technology Group (ACSO): We expect revenue growth to accelerate 18-Feb-2025 / 16:05 GMT/BST The issuer is solely responsible for the content of this announcement. Hardman & Co Research on accesso Technology Group (ACSO): We expect revenue growth to accelerate  In this note, we review the prospects for accesso ahead of the final results in April.  The January update was reassuring, with revenue of ca.$152m ahead of our $150m forecast and the ca.15% cash EBITDA margin well ahead of the 13.2% forecast. Conservatively, we m...

Keith Hiscock ... (+2)
  • Keith Hiscock
  • Mark Thomas

Hardman & Co Monthly: February 2025

Feature article: The October 2024 Budget - We got it wrong By Keith Hiscock, CEO at Hardman & Co In this month's feature article, we review the effects of the 2024 Budget and consider what might happen in the coming months. Our Hardman Monthly of October 2024 looked forward to the first Labour Budget for 14 years. The main theme was that, because the new Chancellor, Rachel Reeves, had ruled out increases in taxes on ‘working people’, investors would bear the brunt of any tax increases to fill ...

Brian Moretta ... (+3)
  • Brian Moretta
  • Mark Thomas
  • Martin Hall

Hardman & Co Monthly: January 2025

Feature article: Hardman & Co Healthcare Index, 2024 – Tough year for Life Sciences By Dr Martin Hall The main function of the HHI is to monitor the performance, and to highlight the attractiveness, of life sciences investments over the long term, and to try to identify those stocks that have disruptive technologies that consistently allow them to outperform both the index and the markets. Many of the 53 constituents of the index are high-risk, with micro-capitalisations and a long way from pro...

Mark Thomas ... (+2)
  • Mark Thomas
  • Martin Hall

The Hardman & Co Monthly: November 2024

Feature article: “ROOM” (Running Out of Money) risk, How managing liquidity risk can sustain corporate value and maintain shareholder confidence As we come close to the end of a very challenging year for many UK entrepreneurs, as well as a frustrating period for shareholders, it is time to address one elephant in the ROOM! ROOM stands for “Running Out of Money”. The risk of doing so, or the perception that it could occur, can destroy corporate values and prematurely paralyse a business. While ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch